Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:REGN
Tag: NASDAQ:REGN
REGENERON PHARMACEUTICALS,INC. (NASDAQ:REGN) Files An 8-K Departure of Directors or Certain...
ME Staff 8-k
-
December 21, 2016
0
Sanofi SA (NYSE:SNY), To Cut 20% Of Diabetes, Cardiovascular Workforce
-
December 13, 2016
0
EMA Reviews Regeneron Pharmaceuticals Inc (NASDAQ:REGN), Sanofi SA (ADR) (NYSE:SNY) Dupixent...
-
December 9, 2016
0
Sanofi SA (NYSE:SNY) Facing Manufacturing Headache On Two Blockbusters
Andy Parker
-
November 30, 2016
0
REGENERON PHARMACEUTICALS,INC. (NASDAQ:REGN) Files An 8-K Termination of a Material Definitive...
ME Staff 8-k
-
November 25, 2016
0
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Faces Trouble With Eylea Amid Strong Sales
-
November 8, 2016
0
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Files An 8-K
ME Staff
-
October 28, 2016
0
Regeneron Pharmaceuticals Inc (NASDAQ:REGN), Teva Pharmaceutical Industries Ltd (NYSE:TEVA) Hit Setback...
-
October 19, 2016
0
FDA Grants Priority Review For Dupilumab BLA FROM Regeneron Pharmaceuticals, Inc....
-
September 27, 2016
0
Regeneron Pharmaceuticals Inc (NASDAQ:REGN), Sanofi SA (NYSE:SNY) Clinch Marketing Authorization for...
-
July 5, 2016
0
1
...
3
4
5
Page 4 of 5